4.6 Article

ParkinSong Online: protocol for a telehealth feasibility study of therapeutic group singing for people with Parkinson's disease

Journal

BMJ OPEN
Volume 11, Issue 12, Pages -

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2021-058953

Keywords

Parkinson's disease; speech pathology; telemedicine; complementary medicine

Funding

  1. National Health and Medical Research Council
  2. Australian Research Council [APP1106603]
  3. Fight Parkinson's

Ask authors/readers for more resources

This study aims to test the feasibility and acceptability of an online singing intervention for people with Parkinson's disease and remote data collection procedures. The primary outcomes focus on recruitment, retention, attendance, safety, intervention fidelity, acceptability, and associated costs. This mode of delivery is designed to increase accessibility of singing interventions for Parkinson's patients.
Introduction Parkinson's disease can be associated with speech deterioration and low communication confidence which in turn compromises social interaction. Therapeutic singing is an engaging method for combatting speech decline; however, face-to-face delivery can limit access to group singing. The aim of this study is to test the feasibility and acceptability of an online mode of delivery for a Parkinson's singing intervention (ParkinSong) as well as remote data collection procedures. Methods and analysis This ParkinSong Online feasibility trial is a single-arm, pre-post study of online singing delivery and remote data collection for 30 people living with Parkinson's. The primary outcome measure is feasibility: recruitment, retention, attendance, safety, intervention fidelity, acceptability and associated costs. Secondary outcomes are speech (loudness, intelligibility, quality, communication-related quality of life) and wellbeing (apathy, depression, anxiety, stress, health-related quality of life). This mode of delivery aims to increase the accessibility of singing interventions. Ethics and dissemination Ethics approval was obtained from The University of Melbourne Human Research Ethics Committee (2021-14465-16053-3) and the trial has been prospectively registered. Results will be presented at national and international conferences, published in a peer-reviewed journal, and disseminated to the Parkinson's community, researchers and policymakers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available